Pparα

Constitutive Knock Out

Pparα Constitutive Knock Out Mouse Model

C57BL/6 Background

  • Model #
  • Genotype
  • Nomenclature
  • 1640-F
    ko/ko
    B6.129S4-Pparatm1Gonz N12
  • 1640-M
    ko/ko
    B6.129S4-Pparatm1Gonz N12
  • Contains a disruption of the Pparα (peroxisome proliferator activated receptor alpha(α)) gene in the ligand-binding coding region
  • Pparα, a member of the nuclear steroid/hormone receptor superfamily, is involved in fatty acid metabolism and transport and mediates the induction of peroxisome proliferation
  • No profound hepatomegaly, peroxisomal proliferation and induction of fatty acid oxidation enzymes in response to classical peroxisome proliferators
  • Higher serum HDL cholesterol and apoA-I concentrations than wild type controls
  • β-oxidation of the long-chain fatty acid, palmitic acid, is lower in mutant mice, demonstrating altered mitochondrial fatty acid metabolism
  • β-oxidation of very long chain fatty acids is not altered
  • Useful in studies of lipid and glucose homeostasis, to study fatty acid metabolism and as a potential model for inborn errors of metabolism

Genetic Background:

C57BL/6 Background

Origin:

The Pparα targeted mutation model was developed by Susana S.T. Lee and colleagues in the laboratory of Frank Gonzalez at the National Cancer Institute. The model was created by targeting the Pparα gene in 129S4 derived J1 ES cells and injecting the targeted cells into C57BL/6N blastocysts. Resultant chimeras were backcrossed to C57BL/6N for eleven generations (N11). Taconic received stock in 2001. Mice were backcrossed to C57BL/6N for embryo transfer derivation (N12). The colony is maintained by incrossing homozygous mice.


Genetics:

Wild type for Nnt mutation; carries Pde6brd1 mutation


Color:

Black

Species:

Mouse

Initial Publication:

Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. (1995) Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol, 15(5):3012-22.



Conditions of Use for Taconic Transgenic Models™
Taconic Transgenic Models™ (Models) are produced and distributed under rights to patents and intellectual property licensed from various institutions. Taconic sells the Models to purchasers, grants to each purchaser a right under Taconic's rights in such licensed patents and intellectual property to use the purchased Model in consideration of purchasers' acknowledgement of and agreement to the Terms and Conditions of Sale and the following terms of use:
  • Title to these Models and biological materials derived from them remains with Taconic Biosciences, Inc.
  • The Models will be used for research purposes only.
  • The Models will not be bred except to obtain embryos or fetuses required for research purposes
  • The Models and biological materials derived from them will not be distributed to third parties or used for commercial purposes.